Hikma Pharmaceuticals falls Friday, underperforms market
Shares of Hikma Pharmaceuticals PLC HIK inched down 0.35% to £19.82 Friday, on what proved to be an all-around favorable ...
FDA approves Hikma’s generic version of Novo’s diabetes drug Victoza
The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug ...
Hikma Pharmaceuticals rises Monday, outperforms market
Hikma Pharmaceuticals PLC HIK shares rose 1.79% to £19.88 Monday, on what proved to be an all-around positive trading session ...
McKnight's Senior Living6h
FDA approves first generic liraglutide once-daily injection
(HealthDay News) — The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma ...
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
ConsumerAffairs1d
FDA approves generic GLP-1 drug to treat type 2 diabetes
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
Yahoo Finance7d
Hikma Pharmaceuticals PLC's (LON:HIK) Stock Is Going Strong: Have Financials A Role To Play?
Most readers would already be aware that Hikma Pharmaceuticals' (LON:HIK) stock increased significantly by 5.3% over the past month. As most would know, fundamentals are what usually guide market ...
Hikma Pharmaceuticals (LON:HIK) Stock Passes Above 200-Day Moving Average – What’s Next?
Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 1,921.22 ($24.37) and ...
US FDA approves Hikma's generic version of Novo's diabetes drug Victoza
The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...
New York Post4d
FDA approves Hikma’s generic version of Novo’s diabetes drug Victoza
The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...
Reuters4d
US FDA approves Hikma's generic version of Novo's diabetes drug Victoza
Dec 23 (Reuters) - The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' (HIK.L), opens new tab generic version of Novo Nordisk's diabetes drug (NOVOb.CO), opens new tab ...